Effects of gamma-decanolactone on seizures induced by PTZ-kindling in mice

Experimental Brain Research

Volumn 187, Issue 1, 2008, Pages 161-166

  De Oliveira, Paulo Alexandre ^a   Lino, Felipe Luis ^a   Cappelari, Shandale Emanuele ^a   Da Silva Brum, Lucimar Filot ^a   Picada, Jaqueline Nascimento ^a   Pereira, Patrícia ^a  

^a UNIVERSIDADE LUTERANA DO BRASIL   (Brazil)

Author keywords

Anticonvulsant; Brain DNA damage; Gamma decanolactone; PTZ kindling; Seizure

Indexed keywords

ANTICONVULSIVE AGENT; GAMMA DECANOLACTONE; PENTETRAZOLE; PHENOBARBITAL; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; DISEASE COURSE; DISEASE SEVERITY; DNA DAMAGE; DOSE RESPONSE; DRUG EFFECT; KINDLING; MALE; MOUSE; NONHUMAN; PRIORITY JOURNAL; SEIZURE;

ANIMALS; ANTICONVULSANTS; BRAIN; COMET ASSAY; CONVULSANTS; DISEASE MODELS, ANIMAL; DNA DAMAGE; DOSE-RESPONSE RELATIONSHIP, DRUG; DRUG ADMINISTRATION SCHEDULE; EPILEPSY; KINDLING, NEUROLOGIC; LACTONES; MALE; MICE; NERVE DEGENERATION; PENTYLENETETRAZOLE; PHENOBARBITAL; TREATMENT OUTCOME;

EID: 42449112457     PISSN: 00144819     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00221-008-1295-y     Document Type: Article

References (24)

1. Ali A, Ahmad FJ, Pillai KK, Vohora D (2005) Amiloride protects against pentylenetetrazole-induced kindling in mice. Br J Pharmacol 145:880-884
2. Becker A, Grecksch G, Brosz M (1995) Antiepileptic drugs-their effects on kindled seizures and kindling-induced learning impairments. Pharmacol Biochem Behav 52:453-459
3. Brum LFS, Elisabetsky E (2000) Antiepileptogenic properties of phenobarbital: behavior and neurochemical analysis. Pharmacol Biochem Behav 67:411-416
4. Coelho de Souza GP, Elisabetsky E, Nunes DS, Rabelo SK, Nascimento da Silva M (1997) Anticonvulsant of properties of γ-decanolactone in mice. J Ethnopharmacol 58:175-181
5. Da Silva LF, Pereira P, Elisabetsky E (1998) A neuropharmacological analysis of PTZ-induced kindling in mice. Gen Pharmacol 31:47-50
6. Dhir A, Naidu OS, Kulkarni SK (2005) Effect of naproxen, a non-selective cyclo-oxygenase inhibitor, on pentylenetetrazol-induced kindling in mice. Clin Exp Pharmacol Physiol 32:579-584
7. Dichter MA (1997) Basic mechanisms of epilepsy: targets for therapeutic intervention. Epilepsia 38:S2-S6
8. Elisabetsky E, Souza GPC, Santos MAC, Siqueira IR, Amador TA (1995) Sedative properties of Linalool. Fitoterapia 15:407-414
9. French JA (2007) Refractory epilepsy: clinical overview. Epilepsia 48:3-7
10. A β2 subunit-containing receptors in mediating the anticonvulsant and sedative effects of loreclezole. Eur J Neurosci 24:167-174
11. Ilhan A, Gure A, Armutcu F, Kamisli S, Iraz M (2005) Antiepileptogenic and antioxidant effects of Nigella sativa oil against pentylenetetrazol-induced kindling in mice. Neuropharmacology 49:456-464
12. Loscher W, Schmidt D (2004) New horizons in the development of antiepileptic drugs: the search for new targets. Epilepsy Res 60:77-159
13. Lukomskaya NY, Lavrent'eva VV, Starshinova LA, Zabkho EP, Gorbunova LV, Tikhonova TB, Gmiro VE, Magazanik LG (2007) Effects os ionotropic glutamate receptors channel blockers on the development ofpentylenetetrazol kindling in mice. Neurosci Behav Physiol 37:75-81
14. Nadin SB, Vargas-Roig ML, Ciocca DR (2001) A silver staining for single-cell gel assay. J Histochem Cytochem 49:1183-1186
15. Pavlova T, Stepanichev M, Gulyaeva N (2006) Pentylenetetrazole kindling induces neuronal cyclin B1 expression in rat hippocampus. Neurosci Lett 392:154-158
16. Pereira P, Elisabetsky E, Souza DO (1997) Effect of γ-decanolactone on glutamate binding in rats cerebral cortex. Neurochem Res 22:1507-1510
17. Picada JN, Flores DG, Zettler CG, Marroni NP, Roesler R, Henriques JAP (2003) DNA damage in brain cells of mice treated with an oxidized form of apomorphine. Mol Brain Res 114:80-85
18. Rogawski MA (1992) The NMDA receptor, NMDA antagonists and epilepsy therapy. Drugs 44:279-292
19. Schmidt D, Rogawski MA (2002) New strategies for the identification of drugs to prevent the development or progression of epilepsy. Epilepsy Res 50:71-78
20. Szyndler J, Piechal A, Blecharz-Klin K, Skorzewska A, Maciejak P, Walkowiak J, Turzynska D, Bidzinski A, Plaznik A, Widy-Tyszkiewicz E (2006) Effect of kindled seizures on rat behavior in water Morris maze test and amino acid concentrations in brain structures. Pharmacol Rep 58:75-82
21. Tice RR, Agurell E, Anderson D, Burlinson B, Hartmann A, Kobayashi Y, Miyamae Y, Rojas E, Ryu JC, Sasaki YF (2000) Single cell gel/comet assay: guidelines for in vitro and in vivo genetic toxicology testing. Environ Mol Mutagen 35:206-221
22. Viana CCS, de Oliveira PA, Brum LFS, Picada JN, Pereira P (2007) Gamma-decanolactone effect on behavioral and genotoxic parameters. Life Sci 80:1014-1019
23. White HS (1997) Clinical significance of animal seizure models and mechanisms of action studies of potential antiepileptic drugs. Epilepsia 38:9-17
24. Wolfgang L (2005) How to explain multidrug resistance in epilepsy? Epilepsy Curr 5:107-112